Guardant Health Inc [GH] stock is trading at $23.00, up 5.12%. An important factor to consider is whether the stock is rising or falling in short-term value. The GH shares have gain 12.14% over the last week, with a monthly amount glided 5.50%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on June 28, 2024, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $36 for it. Guggenheim started tracking the stock assigning a Neutral rating. Wolfe Research initiated its recommendation with a Peer Perform. Raymond James upgraded its rating to Outperform for this stock on November 13, 2023, but kept the price target unchanged to $27. In a note dated September 28, 2023, Bernstein initiated an Outperform rating and provided a target price of $34 on this stock.
Guardant Health Inc [GH] stock has fluctuated between $15.81 and $37.04 over the past year. Currently, Wall Street analysts expect the stock to reach $57.27 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $23.00 at the most recent close of the market. An investor can expect a potential return of 149.0% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 643.81M for the trailing twelve months, which represents a growth of 29.23%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.79%, Pretax Profit Margin comes in at -0.76%, and Net Profit Margin reading is -0.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -4.33 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -724.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.37 points at the first support level, and at 21.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.41, and for the 2nd resistance point, it is at 23.82.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 6.40. On the other hand, the Quick Ratio is 6.07, and the Cash Ratio is 5.14. Considering the valuation of this stock, the price to sales ratio is 4.62.
Transactions by insiders
Recent insider trading involved Joyce Meghan V., Director, that happened on Jun 04 ’24 when 100.0 shares were sold. Chief Information Officer, Kalia Kumud completed a deal on Mar 18 ’24 to buy 2187.0 shares. Meanwhile, Director Joyce Meghan V. sold 100.0 shares on Mar 04 ’24.
